Deformities of the spine, in which the spine is abnormally curved or aligned, can often seriously impact mobility, cause debilitating pain and negatively affect a patients overall quality of life.…
This content is password protected. To view it please enter your password below: Password: The post WCG’s 2024 Clinical Research Site Challenges Report appeared first on WCG. Source: Drug Industry…
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases
Coverage Analysis for Oncology SlidesDownload The post Coverage Analysis for Oncology Trials: Understanding the Nuances and Keys to Success appeared first on WCG. Source: Drug Industry Daily
In the ever-evolving landscape of clinical research, site feasibility and start-up processes remain critical yet challenging aspects that can significantly impact study timelines, costs, and overall success. In a recent…
FDA approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets…
This guidance is one in a series of guidances that provide recommendations regarding eligibility criteria for clinical trials of investigational drugs or biological products for the treatment of cancer. Specifically,…
FDA approved Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing at least 15 kg Source: FDA Press…
Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due…
BTS Research Successfully Completes USDA Inspection with Zero Findings San Diego, CA - August 28, 2024 - BTS Research, a leading contract research organization specializing in preclinical research services, is…